These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 7707401)

  • 1. Updates: cancer drug approved; new leukemia treatment.
    Jenks S; Smigel K
    J Natl Cancer Inst; 1995 Feb; 87(3):167-70. PubMed ID: 7707401
    [No Abstract]   [Full Text] [Related]  

  • 2. Vinorelbine treatment IND program announced.
    Am J Hosp Pharm; 1994 Sep; 51(17):2087. PubMed ID: 7755700
    [No Abstract]   [Full Text] [Related]  

  • 3. Cancer treatment. New drugs, new hope.
    Harv Health Lett; 2001 Jul; 26(9):1-3. PubMed ID: 11511447
    [No Abstract]   [Full Text] [Related]  

  • 4. Emerging drugs for chronic myeloid leukemia.
    Cilloni D; Messa E; Rotolo A; Saglio G
    Expert Opin Emerg Drugs; 2010 Jun; 15(2):175-84. PubMed ID: 20201747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparing antibody and small-molecule therapies for cancer.
    Imai K; Takaoka A
    Nat Rev Cancer; 2006 Sep; 6(9):714-27. PubMed ID: 16929325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New vinca alkaloids and related compounds.
    Budman DR
    Semin Oncol; 1992 Dec; 19(6):639-45. PubMed ID: 1462165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Looking for a miracle.
    Marchant J
    New Sci; 2000 Jun; 166(2244):16-7. PubMed ID: 11902203
    [No Abstract]   [Full Text] [Related]  

  • 8. Part II: management of resistance to imatinib in chronic myeloid leukaemia.
    Apperley JF
    Lancet Oncol; 2007 Dec; 8(12):1116-1128. PubMed ID: 18054881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BCR/ABL: from molecular mechanisms of leukemia induction to treatment of chronic myelogenous leukemia.
    Salesse S; Verfaillie CM
    Oncogene; 2002 Dec; 21(56):8547-59. PubMed ID: 12476301
    [No Abstract]   [Full Text] [Related]  

  • 10. [Target-oriented tumor therapy -- proof of the principle].
    Gastl G; Hiddemann W
    Dtsch Med Wochenschr; 2004 Oct; 129(40):2093. PubMed ID: 15455299
    [No Abstract]   [Full Text] [Related]  

  • 11. Imatinib mesylate, a selective inhibitor of BCR-ABL, in chronic myeloid leukemia.
    Carella AM
    Expert Rev Anticancer Ther; 2007 Mar; 7(3):249-51. PubMed ID: 17338645
    [No Abstract]   [Full Text] [Related]  

  • 12. Prospects of Utilizing Computational Techniques for the Treatment of Human Diseases.
    Nayarisseri A
    Curr Top Med Chem; 2019; 19(13):1071-1074. PubMed ID: 31490742
    [No Abstract]   [Full Text] [Related]  

  • 13. Researchers buoyed by promise of targeted leukemia therapy.
    Stephenson J
    JAMA; 2000 Jan; 283(3):317, 321. PubMed ID: 10647784
    [No Abstract]   [Full Text] [Related]  

  • 14. [Chronic myelogenous leukemia].
    Yoshida C
    Rinsho Ketsueki; 2013 Jan; 54(1):61-70. PubMed ID: 23391648
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of refractory immune cytopenias in the 21st century--how safe is rituximab?
    Ravindranath Y
    Am J Hematol; 2005 Sep; 80(1):92-3. PubMed ID: 16138348
    [No Abstract]   [Full Text] [Related]  

  • 16. Targeted chemotherapy: chronic myelogenous leukemia as a model.
    Sharifi N; Steinman RA
    J Mol Med (Berl); 2002 Apr; 80(4):219-32. PubMed ID: 11976731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imatinib: the promise of a "magic bullet" for cancer fulfilled.
    Henderson CA
    J Med Assoc Ga; 2003; 92(1):12-4, 22. PubMed ID: 12743899
    [No Abstract]   [Full Text] [Related]  

  • 18. Isotretinoin for juvenile chronic myelogenous leukemia.
    Donadieu J
    N Engl J Med; 1995 Jun; 332(22):1521. PubMed ID: 7739704
    [No Abstract]   [Full Text] [Related]  

  • 19. Mechanisms of resistance to tyrosine kinase inhibitors in chronic myeloid leukemia and recent therapeutic strategies to overcome resistance.
    Bixby D; Talpaz M
    Hematology Am Soc Hematol Educ Program; 2009; ():461-76. PubMed ID: 20008232
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treating cancer's kinase 'addiction'.
    Baselga J; Arribas J
    Nat Med; 2004 Aug; 10(8):786-7. PubMed ID: 15286778
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.